Effects of BRCA1/2 on Ovarian and Breast Cancer Survival-Response

被引：3

作者：

Zhong, Qian ^{[1
]}

Peng, Hong-Ling ^{[1
]}

Zhao, Xia ^{[1
]}

Zhang, Lin ^{[2
]}

Hwang, Wei-Ting ^{[2
,3
]}

机构：

[1] Sichuan Univ, West China Univ Hosp 2, Dept Gynecol & Obstet, Chengdu 610064, Peoples R China

[2] Univ Penn, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA

[3] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA

来源：

CLINICAL CANCER RESEARCH | 2015年 / 21卷 / 16期

关键词：

D O I：

10.1158/1078-0432.CCR-15-0931

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3807 / 3807

页数：1

共 50 条

[41] BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer
Thomassen, Mads
Hansen, Thomas V. O.
Borg, Ake
Lianee, Henriette Theilmann
Wikman, Friedrik
Pedersen, Inge Sokilde
Bisgaard, Marie Luise
Nielsen, Finn C.
Kruse, Torben A.
Gerdes, Anne-Marie
[J]. ACTA ONCOLOGICA, 2008, 47 (04) : 772 - 777
[42] Hereditary Breast and Ovarian Cancer Syndrome: Moving Beyond BRCA1 and BRCA2
Hoang, Lien N.
Gilks, Blake C.
[J]. ADVANCES IN ANATOMIC PATHOLOGY, 2018, 25 (02) : 85 - 95
[43] BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer
Schubert, EL
Mefford, HC
Dann, JL
Argonza, RH
Hull, J
King, MC
[J]. GENETIC TESTING, 1997, 1 (01): : 41 - 46
[44] BRCA1 and BRCA2 sequence variants in Algerian breast/ovarian cancer families
Cherbal, Farid
Benais-Pont, Gaelle
Bakour, Rabah
Adane, Saida
Boualga, Kada
Maillet, Philippe
[J]. CANCER RESEARCH, 2010, 70
[45] Hereditary breast and ovarian cancer in Asia:: Genetic epidemiology of BRCA1 and BRCA2
Liede, A
Narod, SA
[J]. HUMAN MUTATION, 2002, 20 (06) : 413 - 424
[46] BRCA1 methylation and BRCA1 mutations in ovarian cancer
Bol, Guus Martinus
van Diest, Paul Joannes
[J]. GYNECOLOGIC ONCOLOGY, 2011, 122 (02) : 459 - 459
[47] A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2
Suman J. Ramus
Lori S. Friedman
Simon A. Gayther
Bruce A.J. Ponder
Lynda G. Bobrow
Marco van der Looji
Janos Papp
Edith Olah
[J]. Nature Genetics, 1997, 15 : 14 - 15
[48] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
Milne, Roger L.
Osorio, Ana
Ramon y Cajal, Teresa
Baiget, Montserrat
Lasa, Adriana
Diaz-Rubio, Eduardo
de la Hoya, Miguel
Caldes, Trinidad
Teule, Alex
Lazaro, Conxi
Blanco, Ignacio
Balmana, Judith
Sanchez-Olle, Gessami
Vega, Ana
Blanco, Ana
Chirivella, Isabel
Esteban Cardenosa, Eva
Duran, Mercedes
Velasco, Eladio
Martinez de Duenas, Eduardo
Tejada, Maria-Isabel
Miramar, Maria-Dolores
Calvo, Maria-Teresa
Guillen-Ponce, Carmen
Salazar, Raquel
San Roman, Carlos
Urioste, Miguel
Benitez, Javier
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
[49] Germline Mutations of BRCA1 and BRCA2 in Korean Breast and/or Ovarian Cancer Families
Kang, Hio Chung
Kim, Il-Jin
Park, Jae-Hyun
Kwon, Hyuk-Jun
Won, Yong-Jin
Heo, Seung Chul
Lee, Sang-Yon
Kim, Kyung-Hee
Shin, Yong
Noh, Dong Young
Yang, Dae-Hyun
Choe, Kuk Jin
Lee, Bong Hwa
Kang, Soon Beom
Park, Jae-Gahb
[J]. HUMAN MUTATION, 2002, 20 (03) : 235
[50] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
Roger L. Milne
Ana Osorio
Teresa Ramón y Cajal
Montserrat Baiget
Adriana Lasa
Eduardo Diaz-Rubio
Miguel de la Hoya
Trinidad Caldés
Alex Teulé
Conxi Lázaro
Ignacio Blanco
Judith Balmaña
Gessamí Sánchez-Ollé
Ana Vega
Ana Blanco
Isabel Chirivella
Eva Esteban Cardeñosa
Mercedes Durán
Eladio Velasco
Eduardo Martínez de Dueñas
María-Isabel Tejada
María-Dolores Miramar
María-Teresa Calvo
Carmen Guillén-Ponce
Raquel Salazar
Carlos San Román
Miguel Urioste
Javier Benítez
[J]. Breast Cancer Research and Treatment, 2010, 119 : 221 - 232

← 1 2 3 4 5 →